Skip to main content
Erschienen in: Obesity Surgery 12/2013

01.12.2013 | Original Contributions

Effectiveness of Intragastric Balloon Treatment for Obese Patients: One-Year Follow-up After Balloon Removal

verfasst von: Chi-Ming Tai, Hung-Yen Lin, Yung-Chieh Yen, Chih-Kun Huang, Wan-Ling Hsu, Ya-Wei Huang, Chi-Yang Chang, Hsiu-Po Wang, Lein-Ray Mo

Erschienen in: Obesity Surgery | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

The Bioenterics Intragastric Balloon (BIB) is effective for weight loss. However, comparisons of its effectiveness between groups with different body mass index (BMI) are rare. This study compared the effectiveness of BIB treatment in patients with BMI <32 kg/m2 and those with BMI ≧32 kg/m2 at the time of BIB removal and at 1 year later.

Methods

Between April 2009 and June 2011, 28 obese patients who completed a full course of BIB treatment were enrolled. There are 16 patients with BMI <32 and 12 with BMI ≧32. Patients who lost more than 20 % of excess weight (% EWL) were categorized as responders.

Results

The BMI significantly fell from 32.4 ± 3.7 to 28.5 ± 3.7 kg/m2 (P < 0.01) at the time of BIB removal. All biochemical measurements except for cholesterol level were significantly improved. The median value of %EWL of all patients at BIB removal was 40.1, and 20 patients (71.4 %) were responders. Adherence to dietitian counseling was significantly better in responders than in non-responders (85 vs. 25 %, respectively; P < 0.01). The percentage of responders at 1 year after BIB removal was significantly higher among patients with BMI <32 than those with ≧32 (62.5 vs. 16.7 %, respectively; P = 0.02).

Conclusions

BIB placement can achieve significant weight loss and improvement of co-morbidities in obese patients. Better adherence to dietitian counseling is associated with better response. Patients with BMI <32 maintain better weight loss at 1 year after BIB removal.
Literatur
1.
Zurück zum Zitat James WP. The epidemiology of obesity: the size of the problem. J Intern Med. 2008;263:336–52.PubMedCrossRef James WP. The epidemiology of obesity: the size of the problem. J Intern Med. 2008;263:336–52.PubMedCrossRef
2.
Zurück zum Zitat Delinsky SS, Latner JD, Wilson GT. Binge eating and weight loss in a self-help behavior modification program. Obesity (Silver Spring). 2006;14:1244–9.CrossRef Delinsky SS, Latner JD, Wilson GT. Binge eating and weight loss in a self-help behavior modification program. Obesity (Silver Spring). 2006;14:1244–9.CrossRef
3.
Zurück zum Zitat Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59.PubMedCrossRef Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59.PubMedCrossRef
4.
Zurück zum Zitat Goldfeder LB, Ren CJ, Gill JR. Fatal complications of bariatric surgery. Obes Surg. 2006;16:1050–6.PubMedCrossRef Goldfeder LB, Ren CJ, Gill JR. Fatal complications of bariatric surgery. Obes Surg. 2006;16:1050–6.PubMedCrossRef
5.
Zurück zum Zitat Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6.PubMedCrossRef Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6.PubMedCrossRef
6.
Zurück zum Zitat Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611–7.PubMedCrossRef Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611–7.PubMedCrossRef
7.
8.
Zurück zum Zitat Mui WL, So WY, Yau PY, et al. Intragastric balloon in ethnic obese Chinese: initial experience. Obes Surg. 2006;16:308–13.PubMedCrossRef Mui WL, So WY, Yau PY, et al. Intragastric balloon in ethnic obese Chinese: initial experience. Obes Surg. 2006;16:308–13.PubMedCrossRef
9.
Zurück zum Zitat Ganesh R, Rao AD, Baladas HG, et al. The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: poor results in Asian patients. Singap Med J. 2007;48:227–31. Ganesh R, Rao AD, Baladas HG, et al. The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: poor results in Asian patients. Singap Med J. 2007;48:227–31.
10.
Zurück zum Zitat Ohta M, Kitano S, Kai S, et al. Initial Japanese experience with intragastric balloon placement. Obes Surg. 2009;19:791–5.PubMedCrossRef Ohta M, Kitano S, Kai S, et al. Initial Japanese experience with intragastric balloon placement. Obes Surg. 2009;19:791–5.PubMedCrossRef
11.
Zurück zum Zitat Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20:1128–32.PubMedCrossRef Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20:1128–32.PubMedCrossRef
12.
Zurück zum Zitat Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.PubMedCrossRef Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.PubMedCrossRef
13.
Zurück zum Zitat Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.PubMedCrossRef Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.PubMedCrossRef
14.
Zurück zum Zitat WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRef WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRef
15.
16.
Zurück zum Zitat Kotzampassi K, Grosomanidis V, Papakostas P, et al. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22:896–903.PubMedCrossRef Kotzampassi K, Grosomanidis V, Papakostas P, et al. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22:896–903.PubMedCrossRef
17.
Zurück zum Zitat Dansinger ML, Tatsioni A, Wong JB, et al. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med. 2007;147:41–50.PubMedCrossRef Dansinger ML, Tatsioni A, Wong JB, et al. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med. 2007;147:41–50.PubMedCrossRef
18.
Zurück zum Zitat Puglisi F, Antonucci N, Capuano P, et al. Intragastric balloon and binge eating. Obes Surg. 2007;17:504–9.PubMedCrossRef Puglisi F, Antonucci N, Capuano P, et al. Intragastric balloon and binge eating. Obes Surg. 2007;17:504–9.PubMedCrossRef
19.
Zurück zum Zitat Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70.PubMedCrossRef Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70.PubMedCrossRef
20.
Zurück zum Zitat Genco A, Lopez-Nava G, Wahlen C, et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23:515–21.PubMedCrossRef Genco A, Lopez-Nava G, Wahlen C, et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23:515–21.PubMedCrossRef
Metadaten
Titel
Effectiveness of Intragastric Balloon Treatment for Obese Patients: One-Year Follow-up After Balloon Removal
verfasst von
Chi-Ming Tai
Hung-Yen Lin
Yung-Chieh Yen
Chih-Kun Huang
Wan-Ling Hsu
Ya-Wei Huang
Chi-Yang Chang
Hsiu-Po Wang
Lein-Ray Mo
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 12/2013
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-013-1027-7

Weitere Artikel der Ausgabe 12/2013

Obesity Surgery 12/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.